TP53 and cancer: In addition to these known cellular factors, cancer cells’ inherent inability to induce a synergistic antiviral state against type I IFN plus TNF, and their mutational inactivation of genes like RB and p53 also allow MYXV infection and replication in diverse types of cancer cells [58,59,60].